InSight Biopharmaceuticals Ltd., a privately-held company, has been one of the pioneers in the field of biosimilars.
Since 1995, InSight has introduced high-added-value biosimilars to important markets through strategic alliances.
Our technological expertise and infrastructure enable full-cycle product development, commercial manufacturing and product commercialization.
Our diverse product portfolio and pipeline includes bulk drug substances and drug products for biosimilars and sophisticated generics.
Concurrently, InSight extensively develops innovative, front-edge biotech products.